Skip to content

The effects of Piacidin in treatment of diabetes

The investigation of the therapeutic effects of Piacidin capsule in patients with type 2 diabetes mellitus: a double-blind study

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20110614006804N3
Enrollment
66
Registered
2024-01-23
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus. E11

Interventions

Intervention group: Includes diabetic patients who receive piacidin capsules (300 mg)..

Sponsors

Bagheiat-allah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1- Blood triglyceride level should be between 150 and 500 mg/dL. 2- HbA1c level should be less than 8.5%. 3- The age of patients should be between 30 and 65 years. 4- Patients should not make any changes in their blood sugar lowering drug regimen or their physical activity.5- Patients should not have systemic diseases or malignancy or chronic kidney or liver diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Quantitative measurement of serum nitric Oxide, glutathione and malondialdehyde levels, blood sugar and lipid levels. Timepoint: before drug administration (day 0) and 3 month after drug administration (day 90). Method of measurement: Oxidative stress and nitric oxide serum levels will be measured using specific biochemical kits, blood sugar and lipids variables will be assessed based on individual laboratory sample results.

Secondary

MeasureTime frame
None applicable. Timepoint: none applicable. Method of measurement: none applicable.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Javad Behzadnia

Bagheiat-allah University of Medical Sciences

behzadnia@bmsu.ac.ir+98 21 8126 2012

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026